Casdin Partners Master Fund, L.P. Maxcyte, Inc. (MXCT) insider trading activity

Casdin Partners Master Fund, L.P. is > 10% Shareholder of MAXCYTE, INC.. Currently has a direct ownership of 10 Million shares of MXCT, which is worth approximately $41.1 Million. The most recent transaction as insider was on Oct 03, 2022, when has been sold 735,786 shares (Common Stock, par value $0.01 per share) at a price of $6.15 per share, resulting in proceeds of $4,525,084. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10M

0% 3M change

0% 12M change

Total Value Held $41.1 Million

Casdin Partners Master Fund, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 03 2022	SELL Open market or private sale	$4,525,084 $6.15 p/Share	735,786 Reduced 6.85%	10,000,000 Common Stock, par valu...
Jul 01 2022	SELL Open market or private sale	$13,912,857 $4.3 p/Share	3,235,548 Reduced 23.16%	10,735,786 Common Stock, par valu...
Jul 30 2021	BUY Open market or private purchase	$23,400,000 $13.0 p/Share	1,800,000 Added 11.41%	13,971,334 Common Stock, par valu...

Also insider at

BLFS

BIOLIFE SOLUTIONS INC Healthcare

> 10% Shareholder

DBTX

Decibel Therapeutics, Inc. Healthcare

> 10% Shareholder

VERV

Verve Therapeutics, Inc. Healthcare

> 10% Shareholder

ABSI

Absci Corp Healthcare

Director

TNYA

Tenaya Therapeutics, Inc. Healthcare

> 10% Shareholder

LAB

STANDARD BIOTOOLS INC. Healthcare

Director

CPM